← Back to Patent Explorer
US4613676A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted 5-amino-4-hydroxyvaleryl derivatives

Assignee: Novartis Corp
•
Filing: 1984-11-14
•
Granted: 1986-09-23
•
Expires: 2004-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula ##STR1## in which R 1 represents hydrogen or acyl, X 1 represents an optionally N-alkylated amino acid residue that is bonded N-terminally to R 1 and C-terminally to X 2 , X 2 represents an optionally N-alkylated amino acid residue that is bonded N-terminally to X 1 and C-terminally to the group --NR 2 --, R 2 represents hydrogen or lower alkyl, R 3 represents hydrogen, alkyl, cycloalkyl, aryl- lower alkyl or aryl, R 4 represents hydroxy or etherified or esterified hydroxy, R 5 represents alkyl, cycloalkyl, aryl-lower alkyl or aryl, and R 6 represents free or substituted amino or substituted hydroxy, and salts of such compounds having salt-forming groups inhibit the blood pressure-increasing action of the enzyme renin and can be used as anti-hypertensives.

Inventors

  • 👤 Walter Fuhrer
  • 👤 Peter Buhlmayer
  • 👤 Vittorio Rasetti
  • 👤 Bernhard Riniker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 09:43
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/36; C07D213/40; A; A61; A61P; A61P43/00; A61P9/00; A61P9/12; C07C; C07C237/00; C07C237/02; C07C237/04; C07C237/06; C07C237/08; C07C237/10; C07C237/12; C07C237/22; C07C237/28; C07C237/42; C07C255/00; C07C255/01; C07C255/32; C07C255/42; C07C255/43; C07C255/44; C07D209/00; C07D209/02; C07D209/04; C07D209/10; C07D209/14; C07D209/16; C07D233/00; C07D233/54; C07D233/64; C07D277/00; C07D277/02; C07D277/20; C07D277/32; C07D277/38; C07D277/44; C07D277/46; C07D295/00; C07D295/04; C07D295/12; C07D295/125; C07D295/13; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804; C07K; C07K5/00; C07K5/02; C07K5/0207; C07K5/0227; C07K9/00; C07K9/001; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/80; Y10S530/86

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 428 words
A process for the preparation of a compound of the formula ##STR33## wherein R 3 is hydrogen, lower alkyl, cycloalkyl, aryl-lower alkyl, or aryl; R 5 is lower alkyl, cycloalkyl, aryl-lower alkyl, or aryl; and R 6 is (A) amino; (B) mono or di-substituted amino or substituted hydroxy, which substituents are selected from (i) unsubstituted and substituted, saturated and unsaturated, aliphatic hydrocarbon radicals having up to and including 18 carbon atoms; and (ii) aromatic, heteroaromatic, aromatic-aliphatic and heteroaromatic-aliphatic radicals having up to and including 18 carbon atoms; (C) a natural alpha-amino acid residue that is N-terminally bound to the group --CO--, said natural alpha-amino acid being C-terminally free, esterified, or amidated; (D) a di- or tri-peptide residue consisting of amino acids selected from natural alpha-amino acids and statin, said di- or tri-peptide being N-terminally bound to the group --CO-- and, being C-terminally free, esterfied, or amidated; and salts thereof comprising: (a) converting a compound of the formula ##STR34## wherein R 3 is as defined above and Z 1 is an amino-protecting group, with a methylide selected from dialkylsulphonium methylide, alkyl or phenyl dialkylamino sulphoxonium methylide, and dialkylsulphoxonium methylide, into an expoxide of the formula ##STR35## wherein Z 1 and R 3 are as defined above; (b) reacting said epoxide of formula (X) with a nucleofugal leaving group X introducing agent to result in the compound of the formula ##STR36## wherein R 3 Z 1 and X are as defined above; (c) reacting a compound of formula (XI) with a carbonyl compound of the formula Ra--(C═O)--R.sub.b (XII) wherein each of R a and R b are independently hydrogen, lower alkyl, aryl, or aryl-lower alkyl, or R a and R b together are an alkylidene or bridged alkylidene having 4-12 carbon atoms, or a reactive derivative of said carbonyl compound, in the presence of an acidic reagent to result in a compound of the formula ##STR37## wherein R a , R b , R 3 , Z 1 , and X are as defined above; (d) reacting said compound of formula (XIII) with a carboxylic acid ester salt of the formula ##STR38## wherein R 5 is as defined above, Z 2 is a carboxy protecting group and Y.sup.⊖ is a cation to yield a compound of the formula ##STR39## wherein R a , R b R 3 , R 5 , Z 1 , and Z 2 are as defined above; (e) removing said carboxy-protecting group Z 2 ; (f) opening the ring of formula (XV) with a solvolysis reagent; and then (g) removing said protecting group Z 1 .
Claim 2
Dependent Claim 428 words
A process for the preparation of a compound of the formula ##STR33## wherein R 3 is hydrogen, lower alkyl, cycloalkyl, aryl-lower alkyl, or aryl; R 5 is lower alkyl, cycloalkyl, aryl-lower alkyl, or aryl; and R 6 is (A) amino; (B) mono or di-substituted amino or substituted hydroxy, which substituents are selected from (i) unsubstituted and substituted, saturated and unsaturated, aliphatic hydrocarbon radicals having up to and including 18 carbon atoms; and (ii) aromatic, heteroaromatic, aromatic-aliphatic and heteroaromatic-aliphatic radicals having up to and including 18 carbon atoms; (C) a natural alpha-amino acid residue that is N-terminally bound to the group --CO--, said natural alpha-amino acid being C-terminally free, esterified, or amidated; (D) a di- or tri-peptide residue consisting of amino acids selected from natural alpha-amino acids and statin, said di- or tri-peptide being N-terminally bound to the group --CO-- and, being C-terminally free, esterfied, or amidated; and salts thereof comprising: (a) converting a compound of the formula ##STR34## wherein R 3 is as defined above and Z 1 is an amino-protecting group, with a methylide selected from dialkylsulphonium methylide, alkyl or phenyl dialkylamino sulphoxonium methylide, and dialkylsulphoxonium methylide, into an expoxide of the formula ##STR35## wherein Z 1 and R 3 are as defined above; (b) reacting said epoxide of formula (X) with a nucleofugal leaving group X introducing agent to result in the compound of the formula ##STR36## wherein R 3 Z 1 and X are as defined above; (c) reacting a compound of formula (XI) with a carbonyl compound of the formula Ra--(C═O)--R.sub.b (XII) wherein each of R a and R b are independently hydrogen, lower alkyl, aryl, or aryl-lower alkyl, or R a and R b together are an alkylidene or bridged alkylidene having 4-12 carbon atoms, or a reactive derivative of said carbonyl compound, in the presence of an acidic reagent to result in a compound of the formula ##STR37## wherein R a , R b , R 3 , Z 1 , and X are as defined above; (d) reacting said compound of formula (XIII) with a carboxylic acid ester salt of the formula ##STR38## wherein R 5 is as defined above, Z 2 is a carboxy protecting group and Y.sup.⊖ is a cation to yield a compound of the formula ##STR39## wherein R a , R b R 3 , R 5 , Z 1 , and Z 2 are as defined above; (e) removing said carboxy-protecting group Z 2 ; (f) opening the ring of formula (XV) with a solvolysis reagent; and then (g) removing said protecting group Z 1 .
Claim 3
Dependent Claim 24 words
The process of claim 1 further comprising separating the individual isomers found in the resultant mixture from step (e) before proceeding to step (f).
Claim 4
Dependent Claim 59 words
The process of claim 1 further comprising replacing the group OZ 2 of formula XV with the group R 6 in place of step e to result in a compound of the formula ##STR40## wherein R a , R b , R 3 , R 5 , Z 1 , and R 6 are defined as in claim 1.

References Cited (Backward Citations)

US4198398A Cited
US4304715A Cited
US4424207A Cited
EP0104041A1 Cited
WO1984003044A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-09-22 1990-03-24 1990-09-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-09-22 1994-03-24 1994-09-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-09-22 1998-03-24 1998-09-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag